Literature DB >> 3710592

Peripheral blood leukocyte counts, erythrocyte sedimentation rate and C-reactive protein in tularemia caused by the type B strain of Francisella tularensis.

H Syrjälä.   

Abstract

The behavior of leukocytes, erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) in tularemia caused by Type B of Francisella tularensis was analyzed in different clinical forms and severities of disease in 101 adult tularemia patients. The mean leukocyte count was 8.3 X 10(9)/l and the leukocyte differential count was also usually normal. The behavior of leukocytes was similar in different clinical forms and severities of tularemia. The changes in differential counts were milder than reported earlier. Both CRP and ESR were higher in severe than in milder forms of tularemia (p less than 0.05 and p less than 0.01, respectively), and CRP was higher in pulmonary than in ulceroglandular tularemia during the second week (p less than 0.05). There were high individual CRP concentrations of up to 225 mg/l in acute tularemia but there were also low CRP values (10-40 mg/l). Thus the behavior of CRP in tularemia resembled that seen in tuberculosis, and CRP did not always allow differentiation of tularemia from viral diseases.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3710592     DOI: 10.1007/bf01644441

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  14 in total

1.  Tularemia: a perusal of three hundred thirty-nine cases.

Authors:  F T DIENST
Journal:  J La State Med Soc       Date:  1963-04

2.  Studies on yato-byo (Ohara's disease, tularemia in Japan). II.

Authors:  S OHARA
Journal:  Jpn J Exp Med       Date:  1955-02

3.  C-reactive protein in respiratory virus infections.

Authors:  O Ruuskanen; A Putto; H Sarkkinen; O Meurman; K Irjala
Journal:  J Pediatr       Date:  1985-07       Impact factor: 4.406

Review 4.  The role of cell-mediated immunity in bacterial infections.

Authors:  H Hahn; S H Kaufmann
Journal:  Rev Infect Dis       Date:  1981 Nov-Dec

5.  C-reactive protein in rapid differentiation of acute epiglottitis from spasmodic croup and acute laryngotracheitis: a preliminary report.

Authors:  H Peltola
Journal:  J Pediatr       Date:  1983-05       Impact factor: 4.406

6.  Value of C reactive protein measurement in tuberculous, bacterial, and viral meningitis.

Authors:  F C de Beer; G F Kirsten; R P Gie; N Beyers; A F Strachan
Journal:  Arch Dis Child       Date:  1984-07       Impact factor: 3.791

7.  C-reactive protein for rapid monitoring of infections of the central nervous system.

Authors:  H O Peltola
Journal:  Lancet       Date:  1982-05-01       Impact factor: 79.321

8.  Humoral immunity against Francisella tularensis after natural infection.

Authors:  P Koskela; A Salminen
Journal:  J Clin Microbiol       Date:  1985-12       Impact factor: 5.948

9.  Airborne transmission of tularemia in farmers.

Authors:  H Syrjälä; P Kujala; V Myllylä; A Salminen
Journal:  Scand J Infect Dis       Date:  1985

10.  Histopathology of human lymph node tularemia caused by Francisella tularensis var palaearctica.

Authors:  S Sutinen; H Syrjälä
Journal:  Arch Pathol Lab Med       Date:  1986-01       Impact factor: 5.534

View more
  6 in total

1.  Guillain-Barré syndrome and tularemia pleuritis with high adenosine deaminase activity in pleural fluid.

Authors:  H Syrjälä; P Koskela; P Kujala; V Myllylä
Journal:  Infection       Date:  1989 May-Jun       Impact factor: 3.553

2.  Serum levels of C-reactive protein in patients with pulmonary tuberculosis and malignant tumors of the chest.

Authors:  P Maasilta; A A Kostiala
Journal:  Infection       Date:  1989 Jan-Feb       Impact factor: 3.553

3.  In vitro susceptibility of Francisella tularensis to fluoroquinolones and treatment of tularemia with norfloxacin and ciprofloxacin.

Authors:  H Syrjälä; R Schildt; S Räisäinen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-02       Impact factor: 3.267

4.  The Cynomolgus Macaque Natural History Model of Pneumonic Tularemia for Predicting Clinical Efficacy Under the Animal Rule.

Authors:  Tina Guina; Lynda L Lanning; Kristian S Omland; Mark S Williams; Larry A Wolfraim; Stephen P Heyse; Christopher R Houchens; Patrick Sanz; Judith A Hewitt
Journal:  Front Cell Infect Microbiol       Date:  2018-04-04       Impact factor: 5.293

5.  Pulmonary tularaemia: a differential diagnosis to lung cancer.

Authors:  Astrid Kravdal; Øystein Olav Stubhaug; Anne Grete Wågø; Magnus Steien Sætereng; Dag Amundsen; Ruta Piekuviene; Annette Kristiansen
Journal:  ERJ Open Res       Date:  2020-06-29

6.  Pediatric Tularemia-A Case Series From a Single Center in Switzerland.

Authors:  Nina Schöbi; Philipp K A Agyeman; Andrea Duppenthaler; Andreas Bartenstein; Peter M Keller; Franziska Suter-Riniker; Kristina M Schmidt; Matthias V Kopp; Christoph Aebi
Journal:  Open Forum Infect Dis       Date:  2022-06-11       Impact factor: 4.423

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.